Literature DB >> 25426252

Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Dobroslav Kyurkchiev1, Ivan Bochev1, Ekaterina Ivanova-Todorova1, Milena Mourdjeva1, Tsvetelina Oreshkova1, Kalina Belemezova1, Stanimir Kyurkchiev1.   

Abstract

According to the minimal criteria of the International Society of Cellular Therapy, mesenchymal stem cells (MSCs) are a population of undifferentiated cells defined by their ability to adhere to plastic surfaces when cultured under standard conditions, express a certain panel of phenotypic markers and can differentiate into osteogenic, chondrogenic and adipogenic lineages when cultured in specific inducing media. In parallel with their major role as undifferentiated cell reserves, MSCs have immunomodulatory functions which are exerted by direct cell-to-cell contacts, secretion of cytokines and/or by a combination of both mechanisms. There are no convincing data about a principal difference in the profile of cytokines secreted by MSCs isolated from different tissue sources, although some papers report some quantitative but not qualitative differences in cytokine secretion. The present review focuses on the basic cytokines secreted by MSCs as described in the literature by which the MSCs exert immunodulatory effects. It should be pointed out that MSCs themselves are objects of cytokine regulation. Hypothetical mechanisms by which the MSCs exert their immunoregulatory effects are also discussed in this review. These mechanisms may either influence the target immune cells directly or indirectly by affecting the activities of predominantly dendritic cells. Chemokines are also discussed as participants in this process by recruiting cells of the immune systems and thus making them targets of immunosuppression. This review aims to present and discuss the published data and the personal experience of the authors regarding cytokines secreted by MSCs and their effects on the cells of the immune system.

Entities:  

Keywords:  Chemokines; Cytokines; Dendritic cells; Immunomodulation; Mesenchymal stem cells

Year:  2014        PMID: 25426252      PMCID: PMC4178255          DOI: 10.4252/wjsc.v6.i5.552

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  234 in total

Review 1.  Soluble intercellular adhesion molecule-1 (sICAM-1): an overview.

Authors:  Anna Maria Witkowska; Maria Halina Borawska
Journal:  Eur Cytokine Netw       Date:  2004 Apr-Jun       Impact factor: 2.737

2.  Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

Authors:  Florian Tögel; Kathleen Weiss; Ying Yang; Zhuma Hu; Ping Zhang; Christof Westenfelder
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-09

3.  Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.

Authors:  Sergej Tomic; Jelena Djokic; Sasa Vasilijic; Dragana Vucevic; Vera Todorovic; Gordana Supic; Miodrag Colic
Journal:  Stem Cells Dev       Date:  2011-02-10       Impact factor: 3.272

4.  TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.

Authors:  V L Heath; E E Murphy; C Crain; M G Tomlinson; A O'Garra
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

5.  Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing.

Authors:  Xiaobing Fu; Bing Han; Sa Cai; Yonghong Lei; Tongzhu Sun; Zhiyong Sheng
Journal:  Wound Repair Regen       Date:  2009 Mar-Apr       Impact factor: 3.617

6.  Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site.

Authors:  T Brabletz; I Pfeuffer; E Schorr; F Siebelt; T Wirth; E Serfling
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

Review 7.  Mesenchymal stem cells and autoimmune diseases.

Authors:  Francesco Dazzi; Mauro Krampera
Journal:  Best Pract Res Clin Haematol       Date:  2011-02-23       Impact factor: 3.020

8.  Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc.

Authors:  L Genestier; S Kasibhatla; T Brunner; D R Green
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

9.  A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation.

Authors:  Jessica S Elman; Matthew Li; Fangjing Wang; Jeffrey M Gimble; Biju Parekkadan
Journal:  J Inflamm (Lond)       Date:  2014-01-07       Impact factor: 4.981

10.  Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation.

Authors:  Luciana Cavalheiro Marti; Lorena Pavon; Patricia Severino; Tatiana Sibov; Daiane Guilhen; Carlos Alberto Moreira-Filho
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-10-09       Impact factor: 2.743

View more
  181 in total

Review 1.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

2.  Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.

Authors:  Koushan Sineh Sepehr; Alireza Razavi; Zuhair Mohammad Hassan; Abdolreza Fazel; Meghdad Abdollahpour-Alitappeh; Majid Mossahebi-Mohammadi; Mir Saeed Yekaninejad; Behrouz Farhadihosseinabadi; Seyed Mahmoud Hashemi
Journal:  Cancer Immunol Immunother       Date:  2020-04-30       Impact factor: 6.968

3.  Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.

Authors:  Giuliana Castello Coatti; Miriam Frangini; Marcos C Valadares; Juliana Plat Gomes; Natalia O Lima; Natale Cavaçana; Amanda F Assoni; Mayra V Pelatti; Alexander Birbrair; Antonio Carlos Pedroso de Lima; Julio M Singer; Francisco Marcelo M Rocha; Giovani Loiola Da Silva; Mario Sergio Mantovani; Lucia Inês Macedo-Souza; Merari F R Ferrari; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

4.  Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study.

Authors:  Alok K Sharma; Nandini Gokulchandran; Pooja P Kulkarni; Hemangi M Sane; Ridhima Sharma; Alitta Jose; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2020-12-25

5.  The Delta Opioid Peptide DADLE Represses Hypoxia-Reperfusion Mimicked Stress Mediated Apoptotic Cell Death in Human Mesenchymal Stem Cells in Part by Downregulating the Unfolded Protein Response and ROS along with Enhanced Anti-Inflammatory Effect.

Authors:  Madhubanti Mullick; Dwaipayan Sen
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

6.  Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation.

Authors:  Angelo S Mao; Berna Özkale; Nisarg J Shah; Kyle H Vining; Tiphaine Descombes; Liyuan Zhang; Christina M Tringides; Sing-Wan Wong; Jae-Won Shin; David T Scadden; David A Weitz; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

7.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

8.  Biologically produced silver chloride nanoparticles from B. megaterium modulate interleukin secretion by human adipose stem cell spheroids.

Authors:  Letícia E Charelli; Nathalia Müller; Karina R Silva; Luís Maurício T R Lima; Celso Sant'Anna; Leandra S Baptista
Journal:  Cytotechnology       Date:  2018-11-01       Impact factor: 2.058

9.  Breast Implant Texturization Does Not Affect the Crosstalk Between MSC and ALCL Cells.

Authors:  Monia Orciani; Miriam Caffarini; Matteo Torresetti; Anna Campanati; Piercamillo Parodi; Giovanni Di Benedetto; Roberto Di Primio
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

10.  Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.

Authors:  Suellen D S Oliveira; Maricela Castellon; Jiwang Chen; Marcelo G Bonini; Xiaowu Gu; Michael H Elliott; Roberto F Machado; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.